Étude de «cost-effectiveness» des médicaments biosimilaires en oncologie

Simple item page
dc.contributor.advisorR. BELBARAKA
dc.contributor.authorLoubna MEKHCHOUN
dc.date.accessioned2023-09-19T14:11:44Z
dc.date.accessioned2026-01-28T12:40:07Z
dc.date.available2023-09-19T14:11:44Z
dc.date.issued2020
dc.description.collaboratorM. M. ZYANI
dc.description.collaboratorMme. M. ZAHLANE
dc.description.collaboratorM. M. GHAZI
dc.identifier.urihttps://toubkal.imist.ma/handle/123456789/21577
dc.identifier.urihttps://doi.org/10.83129/toubkal-2344
dc.language.isofr
dc.publisherFaculté de Médecine et de Pharmacie, Marrakechfr_FR
dc.publisherSciences médicalesfr_FR
dc.subject.otherOncologie
dc.subject.specificBiosimilaires
dc.subject.specificbevacizumab
dc.subject.specificcancer colorectal
dc.subject.specificcancer pulmonaire
dc.subject.specificcoût
dc.titleÉtude de «cost-effectiveness» des médicaments biosimilaires en oncologiefr_FR

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
these55-20.pdf
Size:
3.07 MB
Format:
Adobe Portable Document Format
Download

Collections

Faculté de Médecine et de Pharmacie - Marrakech